Literature DB >> 34740791

Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire.

Tianling Ou1, Wenhui He1, Brian D Quinlan1, Yan Guo1, Mai H Tran1, Pabalu Karunadharma2, Hajeung Park3, Meredith E Davis-Gardner4, Yiming Yin1, Xia Zhang1, Haimin Wang5, Guocai Zhong6, Michael Farzan7.   

Abstract

B cells have been engineered ex vivo to express an HIV-1 broadly neutralizing antibody (bNAb). B cell reprograming may be scientifically and therapeutically useful, but current approaches limit B cell repertoire diversity and disrupt the organization of the heavy-chain locus. A more diverse and physiologic B cell repertoire targeting a key HIV-1 epitope could facilitate evaluation of vaccines designed to elicit bNAbs, help identify more potent and bioavailable bNAb variants, or directly enhance viral control in vivo. Here we address the challenges of generating such a repertoire by replacing the heavy-chain CDR3 (HCDR3) regions of primary human B cells. To do so, we identified and utilized an uncharacterized Cas12a ortholog that recognizes PAM motifs present in human JH genes. We also optimized the design of 200 nucleotide homology-directed repair templates (HDRT) by minimizing the required 3'-5' deletion of the HDRT-complementary strand. Using these techniques, we edited primary human B cells to express a hemagglutinin epitope tag and the HCDR3 regions of the bNAbs PG9 and PG16. Those edited with bNAb HCDR3 efficiently bound trimeric HIV-1 antigens, implying they could affinity mature in vivo in response to the same antigens. This approach generates diverse B cell repertoires recognizing a key HIV-1 neutralizing epitope.
Copyright © 2021 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell receptor; Cas12a; HCDR3; HDR; HIV-1 V2-glycan antibody; Mb2Cas12a; PG16; PG9; SOSIP

Mesh:

Substances:

Year:  2021        PMID: 34740791      PMCID: PMC8753427          DOI: 10.1016/j.ymthe.2021.10.027

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  54 in total

1.  Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

Authors:  Bernd Zetsche; Jonathan S Gootenberg; Omar O Abudayyeh; Ian M Slaymaker; Kira S Makarova; Patrick Essletzbichler; Sara E Volz; Julia Joung; John van der Oost; Aviv Regev; Eugene V Koonin; Feng Zhang
Journal:  Cell       Date:  2015-09-25       Impact factor: 41.582

2.  New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency.

Authors:  Nicole A Doria-Rose; Jinal N Bhiman; Ryan S Roark; Chaim A Schramm; Jason Gorman; Gwo-Yu Chuang; Marie Pancera; Evan M Cale; Michael J Ernandes; Mark K Louder; Mangaiarkarasi Asokan; Robert T Bailer; Aliaksandr Druz; Isabella R Fraschilla; Nigel J Garrett; Marissa Jarosinski; Rebecca M Lynch; Krisha McKee; Sijy O'Dell; Amarendra Pegu; Stephen D Schmidt; Ryan P Staupe; Matthew S Sutton; Keyun Wang; Constantinos Kurt Wibmer; Barton F Haynes; Salim Abdool-Karim; Lawrence Shapiro; Peter D Kwong; Penny L Moore; Lynn Morris; John R Mascola
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

3.  Rad51-mediated double-strand break repair and mismatch correction of divergent substrates.

Authors:  Ranjith Anand; Annette Beach; Kevin Li; James Haber
Journal:  Nature       Date:  2017-04-12       Impact factor: 49.962

Review 4.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

5.  Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1.

Authors:  Takashi Yamano; Bernd Zetsche; Ryuichiro Ishitani; Feng Zhang; Hiroshi Nishimasu; Osamu Nureki
Journal:  Mol Cell       Date:  2017-08-03       Impact factor: 17.970

6.  Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA.

Authors:  Christopher D Richardson; Graham J Ray; Mark A DeWitt; Gemma L Curie; Jacob E Corn
Journal:  Nat Biotechnol       Date:  2016-01-20       Impact factor: 54.908

7.  A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.

Authors:  Jeong Hyun Lee; Raiees Andrabi; Ching-Yao Su; Anila Yasmeen; Jean-Philippe Julien; Leopold Kong; Nicholas C Wu; Ryan McBride; Devin Sok; Matthias Pauthner; Christopher A Cottrell; Travis Nieusma; Claudia Blattner; James C Paulson; Per Johan Klasse; Ian A Wilson; Dennis R Burton; Andrew B Ward
Journal:  Immunity       Date:  2017-04-18       Impact factor: 31.745

8.  Mechanisms of precise genome editing using oligonucleotide donors.

Authors:  Yinan Kan; Brian Ruis; Taylor Takasugi; Eric A Hendrickson
Journal:  Genome Res       Date:  2017-03-29       Impact factor: 9.043

9.  iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity.

Authors:  Christopher L Nobles; Shantan Reddy; January Salas-McKee; Xiaojun Liu; Carl H June; J Joseph Melenhorst; Megan M Davis; Yangbing Zhao; Frederic D Bushman
Journal:  Genome Biol       Date:  2019-01-17       Impact factor: 13.583

10.  Commonality despite exceptional diversity in the baseline human antibody repertoire.

Authors:  Bryan Briney; Anne Inderbitzin; Collin Joyce; Dennis R Burton
Journal:  Nature       Date:  2019-01-21       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.